For over 60 years the ABPI Code of Practice has been key to the UK industry’s self-regulation, and now, as pharma is experiencing its most intense period of change in decades, a new update seeks to ...
The new Code has been updated to reflect changes in the pharma environment The Association of the British Pharmaceutical Industry (ABPI) has launched its new Code of Practice, containing updated ...
Iain Shield (Associate Director – Market Access, Mtech Access) has reviewed the changes to the ABPI Code of Practice, and highlights updates to prescribing information (Clause 12) and considerations ...
The Association of the British Pharmaceutical Industry (ABPI) 2021 Code of Practice comes into force from 1 July, alongside new ABPI Principles to help companies operate to high ethical standards. The ...
More detailed requirements for pharmaceutical companies’ relationships with patient groups and health professionals will be included in the revised ABPI Code of Practice which comes into effect on ...
Angelini was ruled in breach of Clause 2 of the 2021 Code in relation to an in-person presentation by a contracted speaker at a company-organised promotional meeting, and its recording, which ...
Sunovion Pharmaceuticals Europe, Bayer, Astellas UK, Astellas Europe and Menarini Pharma UK SRL have been named in adverts for breaching of the ABPI’s Code of Practice. Sunovion Pharmaceuticals Europe ...
The body representing the UK pharma industry has published a draft 2021 code of practice, and is asking for feedback on the changes by 8 September. The Association of the British Pharmaceutical ...
The Association of the British Pharmaceutical Industry is consulting on its proposed Code of Practice for 2021, which supports industry to operate in a professional, ethical and transparent manner.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback